chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Brought today by parents. Received polio and DTaP vaccines 2 days ago, on Monday morning. Fine on Monday, somewhat tired, but seemed normal. Gave ibuprofen for presumed pain. About 1:30am Tuesday morning woke up feverish and inconsolable until about 4am. Up at 6:30am, better but still fussy. Seemed ok, went to daycare. Daycare called later at 2pm saying pt had fever of 102.5. Last night was normal - eating, drinking, playful. Overnight was normal. Then this morning fever returned with chills. Vomited, purple lips, lethargic. Had received these vaccines in the past without reaction. Febrile reaction to vaccination - Unclear etiology. Reassured that pt is interactive and well-appearing today. Recommended TYLENOL and ibuprofen for fevers as needed. No contraindications to vaccinations in the future. Due for Hib, HepA, and varicella.
Heart issues like racing heart; Heart issues like racing heart; Blood pressure high; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 20 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Seasonal Asthma" (unspecified if ongoing), notes: Seasonal Asthma and uses an inhaler. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number:01), administration date: 2021, when the patient was 19 years old, for COVID-19 Immunization. The following information was reported: CARDIAC DISORDER (non-serious), PALPITATIONS (non-serious) all with onset Apr2021, outcome "not recovered" and all described as "Heart issues like racing heart"; HYPERTENSION (non-serious) with onset Apr2021, outcome "unknown", described as "Blood pressure high". The events "heart issues like racing heart", "heart issues like racing heart" and "blood pressure high" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Last night like around 7:15 pm I got called to the front of the store. When I arrived, patient was laying on the floor. 911 had already been contacted. Their direction was to place her comfortably on her side. I immediately tried to make contact with her. I asked how she was feeling, and what was her name. She didn't initially respond. After 2 more attempts she started talking to me. She  started saying she had a pain in her chest, and didn't have strength in her body. She also made a comment about not feeling well after her vaccine shot. Paramedics arrived 5-8 min after my initial contact with her. They asked for any medical history. The only thing she stated was heart problems in past and high blood sugar. She also stated she did not follow pharmacist's directions to sit down for a couple minutes after the vaccine shot. Paramedics took vitals. Her blood sugar came back high. She requested to be transported to a hospital. Patient has been contacted 3 times, but she has not called back. Voicemail is full and cannot leave a message.
Received Tdap vaccine at 1130. Called to report hive on face and numbness to face and tongue at 1310. Referred to ER now. BENADRYL P.O.
This spontaneous report was received on 08-MAY-2017 from a licensed practical nurse and refers to a 6 month old infant, gender unknown.  There was no information about the patient's concurrent conditions, concomitant therapy or medical history provided.  On 16-SEP-2016, the 6 month old infant received vaccination with an improperly stored dose of ROTATEQ (lot # L046319, expiration date: 28-SEP-2017, dose was not reported), orally. No symptoms were reported. The administered dose of vaccine experienced the temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported.  The licensed practical nurse stated they did not know why the temperature excursions occurred but there were no further excursions.   This is one of several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1705USA004961: US-009507513-1705USA004973: US-009507513-1705USA004965: US-009507513-1705USA004967: US-009507513-1705USA004960: US-009507513-1705USA004952: US-009507513-1608USA012794: US-009507513-1705USA004942: US-009507513-1705USA004943: US-009507513-1705USA004944: US-009507513-1705USA004945: US-009507513-1705USA004946: US-009507513-1705USA004947: US-009507513-1705USA004948: US-009507513-1705USA004949: US-009507513-1705USA004950: US-009507513-1705USA004951: US-009507513-1705USA004953: US-009507513-1705USA004954: US-009507513-1705USA004955: US-009507513-1705USA004956: US-009507513-1705USA004957: US-009507513-1705USA004958: US-009507513-1705USA004959: US-009507513-1705USA004963: US-009507513-1705USA004964: US-009507513-1705USA004966: US-009507513-1705USA004968: US-009507513-1705USA004969: US-009507513-1705USA004970: US-009507513-1705USA004971: US-009507513-1705USA004972: US-009507513-1705USA004974: US-009507513-1705USA004975: US-009507513-1705USA004976: US-009507513-1705USA004977: US-009507513-1705USA004978: US-009507513-1705USA004979: US-009507513-1705USA004980: US-009507513-1705USA004981: US-009507513-1705USA004982: US-009507513-1705USA004983: US-009507513-1705USA004984: US-009507513-1705USA004985: US-009507513-1608USA012908: US-009507513-1608USA012916: US-009507513-1705USA005004: US-009507513-1705USA005005: US-009507513-1705USA005006: US-009507513-1705USA005007: US-009507513-1705USA004887: US-009507513-1705USA004888: US-009507513-1705USA004889: US-009507513-1705USA004890: US-009507513-1705USA004891: US-009507513-1705USA004892: US-009507513-1705USA004893: US-009507513-1705USA004894: US-009507513-1705USA004895: US-009507513-1705USA004896: US-009507513-1705USA004897: US-009507513-1705USA004898: US-009507513-1705USA004899:
Pt received Hep A and flu vaccine while at work in October, a few weeks later he developed a knot on the right arm. We evaluated the area, obtained a culture which was negative, and treated with mupirocin ointment.
Information was received from a licensed vocational nurse referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not reported. On unspecified dates, the patients were administered improperly stored doses of GARDASIL 9 (lot# L024993, expired on 17-OCT-2017 (dose and route unknown). The vaccines were exposed under 48 Fahrenheit degree (F). There was no previous temperature excursion. Digital data logger was involved. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax 12JUN98 & erupted 9JUL98 started on head went down all over body;maculopapular rash
Deep chest congestion, cough, weak upon rising. Took a covid test and it was positive. Called Dr who prescribed Pax Lovid. That suppressed illness, however two day after completion, I started symptoms of shortness of breath, constand sneezing, runny nose , cough, and general feeling poor. I ran a fever of up to 101. I used Tynonal during this time. On set was June 14. By June 27 I was feeling better , June 29 tested positive. Congestion, and shortness of breath continued.. july 12 tested negative. Still short of breath, dizzy when bending and straightening.
vasculitis; Having allergic reactions to products that I have used that whole time; Unable to do my job without special accommodations; Spongiotic psoriaform dermatitis with lymphocytes and hystocytes/ Allergic skin reactions; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (Spongiotic psoriaform dermatitis with lymphocytes and hystocytes/ Allergic skin reactions), VASCULITIS (vasculitis), HYPERSENSITIVITY (Having allergic reactions to products that I have used that whole time) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to do my job without special accommodations) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #025L20A and #011J20A) for COVID-19 vaccination.     The patient's past medical history included Nephrostomy. Concurrent medical conditions included Drug allergy (Cipro), Drug allergy (Vanc), Fruit allergy (Mellon), Allergy to sting (Bees) and Penicillin allergy (Allergy to PCN).   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced DERMATITIS ALLERGIC (Spongiotic psoriaform dermatitis with lymphocytes and hystocytes/ Allergic skin reactions). On an unknown date, the patient experienced VASCULITIS (vasculitis), HYPERSENSITIVITY (Having allergic reactions to products that I have used that whole time) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to do my job without special accommodations). At the time of the report, DERMATITIS ALLERGIC (Spongiotic psoriaform dermatitis with lymphocytes and hystocytes/ Allergic skin reactions) had not resolved and VASCULITIS (vasculitis), HYPERSENSITIVITY (Having allergic reactions to products that I have used that whole time) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to do my job without special accommodations) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter. Took several courses of steroids, tried several creams and ointments as a treatment.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2021: Significant follow-up added (Nephrostomy) on 25-Aug-2021; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
My throat felt like it was closing up. I had trouble swallowing. I got scared that it wasn?t going to stop so I had to go to the ER. But it didn?t get very very bad, and after an hour or so at the ER my throat started going back to normal and I was fine.
[Moderna COVID-19 vaccine] treatment under Emergency Use Authorization(EUA): Patient presented to the hospital with acute onset of a severe rash cover. Patient had received the Moderna Covid  vaccine on 1/21 in his left arm. Caregivers noted the rash on 1/27. Concern for drug rash secondary to anti-epileptics or the Moderna vaccine. Neurology was consulted to this patient because of concern the drug rash could be secondary to his anti-epileptics (Keppra and valproic acid). The patient had been taking these anti-epileptics since 2003 but he was switched to vimpat during his inpatient stay as a precaution. Given the timeline of the rash in relation to his COVID vaccine, witness also concerned that it could have been a reaction to the vaccine. Valproic acid and Keppra discontinued. Vimpat initiated instead. Patient received steroids, Benadryl, Claritin, and famotidine to treat rash. Rash resolved and patient was discharged 2/15/21. A and B-Skin, leg and chest (site not specified), biiopsy: -Intraepidermal acute inflammation consistent with macropustule formation with mild-moderate superficial dermal inflammatory infiltrate composed of lymphocytes, neutrophils, and occasional eosinophils, See note. Note: The differential diagnosis includes pustular drug eruption and infection. Gram staining is noncontributory. Clinical correlation is required.
No adverse effect; the patient was administede with improperly stored PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's concurrent condition and medical history was not provided. On 04-APR-2019, the patient was vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live rha (PROQUAD) injection (product storage error) lot # R020678 and expiry date reported as 15-JAN-2020 (strength, dose # and route of administration were not reported) for prophylaxis which was reconstituted with properly stored sterile diluent. No adverse effects were reported. It was reported that, the vaccine underwent temperature excursion (32.57 Fahrenheit) 15 degree Fahrenheit to 46 degree Fahrenheit between the time frame of 22 hours. There were no previous temperature excursions. There was an involvement of digital data logger. There was no associated product quality complaint.
Pt passed out and hit his head, now cant see from his left eye. Pt can see from right eye but left eye is blurry. Pt was hospitalized. Pt given Tylenol, Motrin, Benadryl, Zofran, bolus, heparin, Compazine, Toradol and florescent slide for his left eye. Pt came by squad to ER then admitted to pediatric floor for observation.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 13-JUN-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # M003434 with expiry date on 19-JUL-2017, therapy type, dose and route of administration were not reported). No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Nasal congestion, uvular edema/erythema, stridor. Received 2 doses of epi followed by oral benadryl 50 mg and 32 mg methylprednisolone; albuterol. Needed an additional 2 doses of epinephrine. Monitored for 3 hours.
Alerting VAERS of MIS-C occurring after post-COVID-19 vaccination. 11/22/21 - First COVID-19 vaccine; 11/25/21 - First COVID-19 positive antigen test; 12/1/21 - Second COVID-19 positive antigen test; 12/13/21 - Second COVID-19 vaccine; 12/31/21 - Symptoms of MIS-C began; 1/7/22 - Hospitalization for MIS-C; 1/7 - SARS-COV-2 nucleocapsid antibody IgG: positive. Upon admission, patient was fatigued with a mild cough and conjunctivitis. Initial evaluations were notable for elevated troponin and initial EKG and echocardiogram negative for cardiac dysfunction. For treatment of MIS-C, patient received IVIG, low-dose steroids, and aspirin therapy (following improvement of an initial thrombocytopenia). His IVIG infusion was complicated by development diffuse urticarial rash, fever, and supplemental oxygen requirement, consistent with an infusion reaction, with only a small portion of the dose remaining; he was treated with Benadryl and pulse steroids with improvement of symptoms. A chest x-ray the following day revealed an enlarged cardiac silhouette and increased pleural effusions, potentially due to MIS-c vs transfusion reaction. Patient received Lasix with subsequent improvement in his respiratory status. Patient's troponin levels continued to downtrend and patient completed three days of high-dose IV pulse steroids followed by repeat echocardiogram (most recent results detailed below) prior to discharge. He was discharge home with significant improvement in his clinical status with a steroid taper plan and cardiology follow-up.
Pt's developed a rash under injection site after 24 hrs size 6x3 inches.
don't feel good with upset stomachs all the time; don't feel good with upset stomachs all the time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 16 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 30Apr2021 (Batch/Lot number: unknown) at the age of 16 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: MALAISE (non-serious), ABDOMINAL DISCOMFORT (non-serious) all with onset 30Jun2021, outcome "not recovered" and all described as "don't feel good with upset stomachs all the time". The event "don't feel good with upset stomachs all the time" and "don't feel good with upset stomachs all the time" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of malaise, abdominal discomfort.  Additional information: No known allergies.  Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 nor tested for COVID-19 since the vaccination.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-202101206897 same reporter/drug/event, different patient
Pt reported feeling dizzy, thirsty. Arms began "twitching" which progressed to all extremities, body begain to "jolt." Patient's parents took him to ER where they drew blood for testing, which came back negative. He received Ativan and was discharged at 3:30 AM.
A noticeable amount of the vaccine leaked back out of the injection site. It is unknown how much vaccine was lost, so the pharmacist on duty offered a second dose to the patient and she declined. The injection was given by a certified technician, yet the patient blamed him for improper technique. The pharmacist reviewed video footage which showed no apparent issues with the technician's injection technique.
Fever up to 102; headache; severe malise; itching and redness at injection site - treated with Alleve, rest & fluids
Vaccination site has swollen into a knot with a red rash, the size of the rash is large covering my entire back side of the arm. The injection site constantly stings and is warm to the touch. It has been two days since the shot.
no AE; the vaccine was given in error; This spontaneous report was received from a licensed practical nurse and refers to a 45-year-old patient of unknown gender. No information regarding the patient's concurrent conditions, medical history or concomitant medications was provided.  On 09-NOV-2020, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) lot # T021485 and expiration date: 15-MAR-2022 (exact dose, frequency and route of administration were not reported) for prophylaxis. The nurse stated that the vaccine was given "in error". No adverse events (AE) were reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T021485; expirationdate: 15-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
I noticed that I started waking up with swollen and painful hand every morning. It would resolve within a few hours but it got worse with time and I was put on high dose steroids. It made a difference, but when I discontinued the perezone, it came back. They put me on it again, a medium dose this time, however my doctor has started testing me for rheumatoid arthritis. Should I come back positive, this tells me that my immune system had a response to this vaccine, and now I have to live with this for the rest of my life.
Adverse reactions:  At first very sore arm at injection site. Beginning August 28th two days after 1st dose: Increased fatigue, heaviness in my head, feeling very foggy and unclear, trouble with word finding. These feelings in my head very in intensity and tend to feel better upon waking and intensify throughout the day.  Also increased heart palpitations and muscle spasms/twitches that jump throughout my body. These symptoms feel very much like Lymes Disease symptoms and I have no doubt that this is a flare of my condition.  It has now been three weeks post vaccine and I do feel as though my symptoms are improving.
When I got the shot my arm was very pin and it hurt very bad, a few hours later my arm was red and had a lump the size of a quarter, it was swelling constantly everyday.  I also had flu like symptoms for about a day or two but they went away, I went to urgent care and they gave me an antiobiotic to take every day for seven days.  My arm was still hot and red for a few day but now it is almost back to normal, the swelling has gone down and the itchy and other things have gone away as well.
He had tingling and numbness in skin, then back pain, then he had difficulty urinating, then he had persistent tachycardia, then his tingling and numbness were worse and worse then he was diagnosed with chronic inflammatory demyelinating polyneuritis.
Unable to dress herself; "Terrible" left arm pain; Was up all night; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2019, the patient received the 1st dose of Shingrix. On 11th November 2019, 3 hrs after receiving Shingrix, the patient experienced pain in arm and insomnia. On an unknown date, the patient experienced activities of daily living impaired. On an unknown date, the outcome of the pain in arm was recovering/resolving and the outcome of the insomnia and activities of daily living impaired were unknown.   It was unknown if the reporter considered the pain in arm, insomnia and activities of daily living impaired to be related to Shingrix.  Additional details were received as follows: The reporter stated that the patient developed terrible arm pain and was up all night and two days later sough medical attention for the pain. The patient stated that the pain continues at the time of reporting and patient was still seeking medical care for relief, and that she is unable to dress herself, her husband has to hook her bra for her. The reporter stated that the patient had no previous issues with her arm. The reporter consented to follow up.
Chronic urticaria since about April 2003.  (Exact date of onset not clear)